Leslie A. Wanek

Saint John's Health Center — United States

Medicine · Health Sciences

26h-index3.8kcitations42works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cutaneous Melanoma Detection and Management(35), Immunotherapy and Immune Responses(15), Cancer Immunotherapy and Biomarkers(8), Melanoma and MAPK Pathways(7), Nonmelanoma Skin Cancer Studies(6)

Publications42 total

Improved Survival for Stage IV Melanoma From an Unknown Primary Site
Journal of Clinical Oncology·2009· 93 citedOpen Access
Improved Survival After Lymphadenectomy for Nodal Metastasis From an Unknown Primary Melanoma
Journal of Clinical Oncology·2008· 130 citedOpen Access
Improved survival following lymphadenectomy for nodal metastasis from an unknown primary melanoma
Journal of Clinical Oncology·2007
Improved long-term survival in patients with intermediate thickness primary melanoma managed by sentinel node biopsy
Journal of Clinical Oncology·2007
Lessons learned from two decades of sentinel node biopsies for melanoma
Journal of Clinical Oncology·2006
Prognostic significance of children with cutaneous melanoma: Implications for treatment
Journal of Clinical Oncology·2006
Can Surgical Therapy Alone Achieve Long-Term Cure of Melanoma Metastatic to Regional Nodes?
The Cancer Journal·2006· 20 cited
Sentinel Lymphadenectomy Does Not Increase the Incidence of In-Transit Metastases in Primary Melanoma
Journal of Clinical Oncology·2005· 77 citedOpen Access
Age and gender influence the progression of AJCC Stage I/II melanoma
Journal of Clinical Oncology·2005· 1 cited
Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes After Tumor-Positive Sentinel Lymph Node Dissection for Melanoma
Journal of Clinical Oncology·2004· 173 citedOpen Access
Sentinel lymphadenectomy guided complete lymph node dissection improves loco-regional disease control in early-stage head and neck melanoma
Journal of Clinical Oncology·2004
Sentinel lymphadenectomy guided complete lymph node dissection improves loco-regional disease control in early-stage head and neck melanoma
Journal of Clinical Oncology·2004
Active specific immunotherapy with a polyvalent cancer vaccine prolongs survival in AJCC stage IV melanoma
Journal of Clinical Oncology·2004· 1 cited
Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors
Journal of the American College of Surgeons·2003· 36 cited
Is Sentinel Lymph Node Mapping Indicated for Isolated Local and In-Transit Recurrent Melanoma?
Annals of Surgery·2003· 66 citedOpen Access
Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma
Annals of Surgery·2003· 271 citedOpen Access
Role of Sentinel Lymphadenectomy in Thin Invasive Cutaneous Melanomas
Journal of Clinical Oncology·2003· 146 cited
Prognostic implications of thick (≥4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy
Annals of Surgical Oncology·2002· 74 cited
Prolonged Survival of Patients Receiving Active Immunotherapy With Canvaxin Therapeutic Polyvalent Vaccine After Complete Resection of Melanoma Metastatic to Regional Lymph Nodes
Annals of Surgery·2002· 147 citedOpen Access
Enhanced Humoral Immune Response Correlates With Improved Disease-Free and Overall Survival in American Joint Committee on Cancer Stage II Melanoma Patients Receiving Adjuvant Polyvalent Vaccine
Journal of Clinical Oncology·2002· 59 cited
page 1 of 3Next →

Frequent Co-authors

Donald L. Morton(24), Richard Essner(21), Leland J. Foshag(12), D L Morton(9), Robert M. Elashoff(7), Dave S.�B. Hoon(6), Rishab K. Gupta(6), Eddy C. Hsueh(6), Donald L. Morton(6), J. Anne Nizze(5), Mark B. Faries(5), L. Andrew DiFronzo(4), Stacey L. Stern(3), Steven O’Day(3), Randall P. Scheri(3), Cindy M. Chang(2), D. G. Davtyan(2), Reiko F. Irie(2), Alistair J. Cochran(2), Edwin C. Glass(2)